Ocular Therapeutix Stock Price History
| OCUL Stock | USD 7.47 0.23 2.99% |
Below is the normalized historical share price chart for Ocular Therapeutix extending back to July 25, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ocular Therapeutix stands at 7.47, as last reported on the 20th of March, with the highest price reaching 7.75 and the lowest price hitting 7.36 during the day.
If you're considering investing in Ocular Stock, it is important to understand the factors that can impact its price. Ocular Therapeutix maintains Sharpe Ratio (i.e., Efficiency) of -0.0197, which implies the firm had a -0.0197 % return per unit of risk over the last 3 months. Ocular Therapeutix exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocular Therapeutix's Coefficient Of Variation of (1,688), variance of 16.79, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide.
At this time, Ocular Therapeutix's Stock Based Compensation is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 332.2 M this year, although the value of Capital Stock will most likely fall to 9,586. . At this time, Ocular Therapeutix's Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 4.50 this year, although the value of Price Earnings Ratio will most likely fall to (7.33). Ocular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2014 | 200 Day MA 8.3356 | 50 Day MA 7.6638 | Beta 1.332 |
Ocular |
Sharpe Ratio = -0.0197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OCUL |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ocular Therapeutix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocular Therapeutix by adding Ocular Therapeutix to a well-diversified portfolio.
Price Book 3.883 | Enterprise Value Ebitda (6.06) | Price Sales 19.2155 | Shares Float 124.1 M | Wall Street Target Price 17.4546 |
Ocular Therapeutix Stock Price History Chart
There are several ways to analyze Ocular Stock price data. The simplest method is using a basic Ocular candlestick price chart, which shows Ocular Therapeutix price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 7, 2025 | 9.08 |
| Lowest Price | March 3, 2025 | 5.93 |
Ocular Therapeutix March 20, 2025 Stock Price Synopsis
Various analyses of Ocular Therapeutix's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ocular Stock. It can be used to describe the percentage change in the price of Ocular Therapeutix from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ocular Stock.| Ocular Therapeutix Price Rate Of Daily Change | 0.97 | |
| Ocular Therapeutix Price Daily Balance Of Power | (0.59) | |
| Ocular Therapeutix Price Action Indicator | (0.20) |
Ocular Therapeutix March 20, 2025 Stock Price Analysis
Ocular Stock Price History Data
The price series of Ocular Therapeutix for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 3.63 with a coefficient of variation of 8.76. The daily prices for the period are spread out with arithmetic mean of 7.91. The median price for the last 90 days is 7.9.| Open | High | Low | Close | Volume | ||
03/20/2025 | 7.70 | 7.75 | 7.36 | 7.47 | ||
| 03/19/2025 | 7.37 | 7.75 | 7.36 | 7.70 | 1,481,486 | |
| 03/18/2025 | 8.24 | 8.25 | 7.44 | 7.45 | 1,541,419 | |
| 03/17/2025 | 7.71 | 7.95 | 7.53 | 7.94 | 1,635,138 | |
| 03/14/2025 | 7.93 | 8.14 | 7.72 | 7.72 | 1,400,725 | |
| 03/13/2025 | 8.41 | 8.56 | 7.87 | 7.88 | 1,397,753 | |
| 03/12/2025 | 8.60 | 8.92 | 8.31 | 8.43 | 2,252,904 | |
| 03/11/2025 | 7.77 | 8.64 | 7.77 | 8.51 | 3,012,583 | |
| 03/10/2025 | 7.43 | 7.69 | 7.26 | 7.65 | 1,467,318 | |
| 03/07/2025 | 7.33 | 7.65 | 7.25 | 7.54 | 1,384,888 | |
| 03/06/2025 | 7.00 | 7.50 | 6.95 | 7.34 | 1,504,275 | |
| 03/05/2025 | 6.53 | 7.21 | 6.51 | 7.15 | 2,835,067 | |
| 03/04/2025 | 5.82 | 6.63 | 5.79 | 6.50 | 2,928,437 | |
| 03/03/2025 | 6.94 | 7.15 | 5.87 | 5.93 | 2,789,215 | |
| 02/28/2025 | 6.88 | 7.14 | 6.85 | 7.14 | 1,217,232 | |
| 02/27/2025 | 6.89 | 7.19 | 6.89 | 6.94 | 910,120 | |
| 02/26/2025 | 6.77 | 7.01 | 6.76 | 6.94 | 931,926 | |
| 02/25/2025 | 6.76 | 6.92 | 6.65 | 6.77 | 1,083,662 | |
| 02/24/2025 | 6.99 | 7.08 | 6.70 | 6.73 | 1,056,364 | |
| 02/21/2025 | 7.35 | 7.41 | 6.99 | 7.00 | 661,570 | |
| 02/20/2025 | 7.36 | 7.42 | 7.22 | 7.25 | 564,676 | |
| 02/19/2025 | 7.18 | 7.39 | 7.17 | 7.38 | 589,521 | |
| 02/18/2025 | 7.25 | 7.52 | 7.14 | 7.20 | 979,767 | |
| 02/14/2025 | 7.48 | 7.68 | 7.18 | 7.28 | 1,401,769 | |
| 02/13/2025 | 7.53 | 7.66 | 7.44 | 7.48 | 915,536 | |
| 02/12/2025 | 7.29 | 7.51 | 7.28 | 7.46 | 854,738 | |
| 02/11/2025 | 7.28 | 7.53 | 7.20 | 7.44 | 1,334,316 | |
| 02/10/2025 | 7.61 | 7.68 | 7.19 | 7.39 | 1,099,365 | |
| 02/07/2025 | 7.62 | 7.78 | 7.53 | 7.57 | 770,153 | |
| 02/06/2025 | 8.15 | 8.20 | 7.63 | 7.64 | 1,033,927 | |
| 02/05/2025 | 7.80 | 8.31 | 7.71 | 8.13 | 935,994 | |
| 02/04/2025 | 7.55 | 7.89 | 7.52 | 7.82 | 904,687 | |
| 02/03/2025 | 7.55 | 7.82 | 7.45 | 7.55 | 1,029,861 | |
| 01/31/2025 | 7.80 | 8.00 | 7.57 | 7.70 | 1,078,592 | |
| 01/30/2025 | 7.94 | 8.04 | 7.61 | 7.78 | 1,543,835 | |
| 01/29/2025 | 7.83 | 8.15 | 7.81 | 7.84 | 838,903 | |
| 01/28/2025 | 7.91 | 7.96 | 7.74 | 7.90 | 616,558 | |
| 01/27/2025 | 7.89 | 8.15 | 7.76 | 7.89 | 929,749 | |
| 01/24/2025 | 7.95 | 8.10 | 7.81 | 7.97 | 713,860 | |
| 01/23/2025 | 7.91 | 8.19 | 7.91 | 7.98 | 1,144,364 | |
| 01/22/2025 | 8.09 | 8.09 | 7.85 | 7.99 | 954,868 | |
| 01/21/2025 | 8.13 | 8.13 | 7.96 | 8.09 | 563,538 | |
| 01/17/2025 | 8.15 | 8.18 | 7.99 | 8.01 | 519,759 | |
| 01/16/2025 | 8.20 | 8.21 | 7.99 | 8.05 | 845,847 | |
| 01/15/2025 | 8.15 | 8.38 | 7.99 | 8.13 | 1,041,878 | |
| 01/14/2025 | 8.25 | 8.43 | 7.70 | 7.86 | 1,318,876 | |
| 01/13/2025 | 8.03 | 8.17 | 7.75 | 8.12 | 1,090,656 | |
| 01/10/2025 | 8.64 | 8.80 | 8.04 | 8.21 | 1,018,743 | |
| 01/08/2025 | 9.03 | 9.14 | 8.82 | 8.87 | 723,737 | |
| 01/07/2025 | 8.95 | 9.22 | 8.80 | 9.08 | 927,395 | |
| 01/06/2025 | 8.86 | 9.18 | 8.78 | 8.88 | 909,142 | |
| 01/03/2025 | 8.85 | 9.02 | 8.76 | 8.76 | 545,020 | |
| 01/02/2025 | 8.60 | 8.86 | 8.56 | 8.74 | 651,128 | |
| 12/31/2024 | 8.44 | 8.57 | 8.23 | 8.54 | 1,296,998 | |
| 12/30/2024 | 8.40 | 8.44 | 8.12 | 8.35 | 829,089 | |
| 12/27/2024 | 8.53 | 8.53 | 8.27 | 8.44 | 1,106,634 | |
| 12/26/2024 | 8.28 | 8.64 | 8.28 | 8.54 | 540,370 | |
| 12/24/2024 | 8.53 | 8.56 | 8.28 | 8.33 | 487,851 | |
| 12/23/2024 | 8.50 | 8.66 | 8.35 | 8.56 | 697,960 | |
| 12/20/2024 | 8.31 | 8.62 | 8.31 | 8.50 | 1,431,144 | |
| 12/19/2024 | 8.63 | 8.76 | 8.37 | 8.45 | 788,984 |
About Ocular Therapeutix Stock history
Ocular Therapeutix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocular Therapeutix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocular Therapeutix stock prices may prove useful in developing a viable investing in Ocular Therapeutix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 158.3 M | 166.2 M | |
| Net Loss | -63.9 M | -67.1 M |
Ocular Therapeutix Quarterly Net Working Capital |
|
Ocular Therapeutix Stock Technical Analysis
Ocular Therapeutix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Ocular Therapeutix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ocular Therapeutix's price direction in advance. Along with the technical and fundamental analysis of Ocular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | 0.0932 | |||
| Treynor Ratio | (0.25) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets | Return On Equity |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.